- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06829680
Investigation of the Effects of Pilates Training Combined with Whole Body Vibration on Balance and Mobility in Individuals with Multiple Sclerosis
The aim of this study is to investigate the effects of Pilates training combined with whole-body vibration (WBV) on balance and mobility in individuals with Multiple Sclerosis (MS). The main questions it aims to answer are:
- Are the improvements in core stability, lower limb functional muscle strength, balance and mobility obtained with Pilates training combined with WBV (Pilates-WBV) in individuals with MS greater than with Pilates training alone?
- Are the improvements in upper extremity performance and fatigue obtained with Pilates-WBV training in individuals with MS greater than with Pilates training alone?
Researchers will compare Pilates-WBV training with a group that received Pilates training alone to see if there is any additional benefit.
Participants will:
- Take Pilates-WBV or Pilates training twice a week for 6 weeks
- Be evaluated with pre- and post-training
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06490
- Gazi University, Faculty of Health Science, Department of Physiotherapy and Rehabilitation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Definitive Multiple Sclerosis diagnosed by a specialist
- Expanded Disability Status Scale (EDSS) score between 0-5
- Accepting participation in the study voluntarily
Exclusion Criteria:
- An MS attack within the last three months
- Pregnancy
- Endoprosthesis or electronic implant
- A cardiovascular, pulmonary or orthopedic disease
- A disease that can affect the immune system, such as infection or cancer
- Additional neurological disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pilates-WBV
17 participants received Pilates and WBV training twice a week for 6 weeks.
In each training session, the participants rested for 10 minutes between Pilates and WBV training.
|
The participants were given a total of 12 sessions of Pilates training, applied twice a week for 6 weeks, and each session lasted approximately 60 minutes. The 60-min session consisted of warm up and cool down (5 min each) and the main active phase (50 min). In the main active phase; "One leg stretch", "Double leg stretch", "One leg circle", "Heels together toes apart", "Shoulder bridge", "The hundreds", "Chest lift", "Criss cross", "Clam", "Side bend", "Arm opening", "Cobra", "Breast stroke", "Swimming", "Modified push-up", "Plank", "Leg pull prone" and "Squat" exercises were performed. The exercises were applied with 10 repetitions in the first 3 weeks and with 20 repetitions in the last 3 weeks. The participants were given a total of 12 sessions of WBV training, applied twice a week for 6 weeks. The vibration parameters were set as frequency: 20 Hz, amplitude: 2-3 mm, duration: 30-60 s and rest period: 60 s. The application time of the WBV training was 30 s for the first two weeks, 45 s for the next two weeks and 60 s for the last two weeks. The individuals were asked to maintain squat, shoulder bridge and quadruped positions statically for the first two weeks. Starting from the third week, they were asked to perform reciprocal upper extremity flexion and extension movements during the positions. The application was repeated 3 times in each position. |
|
Active Comparator: Pilates
17 participants received Pilates training twice a week for 6 weeks
|
The participants were given a total of 12 sessions of Pilates training, applied twice a week for 6 weeks, and each session lasted approximately 60 minutes. The 60-min session consisted of warm up and cool down (5 min each) and the main active phase (50 min). In the main active phase; "One leg stretch", "Double leg stretch", "One leg circle", "Heels together toes apart", "Shoulder bridge", "The hundreds", "Chest lift", "Criss cross", "Clam", "Side bend", "Arm opening", "Cobra", "Breast stroke", "Swimming", "Modified push-up", "Plank", "Leg pull prone" and "Squat" exercises were performed. The exercises were applied with 10 repetitions in the first 3 weeks and with 20 repetitions in the last 3 weeks. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Activities-specific Balance Confidence Scale
Time Frame: From enrollment to the end of treatment at 6 weeks
|
The Activities-specific Balance Confidence Scale (ABC) evaluates balance confidence in daily living activities and includes 16 activities related to balance.
Participants were asked to rate their perceived safety while performing these activities and their perceived risk of falling on a scale from 0 (completely unsafe) to 100 (completely safe).
The total score is calculated by dividing the score by 16 and ranges from 0 to 100.
Scores closer to zero indicate greater balance impairment and a higher risk of falls.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Five Times Sit-to-Stand Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
Lower extremity functional muscle strength was assessed by the Five Times Sit-to-Stand Test.
The individuals were seated in a standard chair with arm support of 43-45 cm height, with their arms crossed on their chests.
When the command "Start" was given, individuals were asked to stand up as quickly as possible and sit down and stand up 5 times.
The score was the total time in seconds to complete the task.
In the study, the test was repeated twice and the shortest time was recorded.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Timed Up and Go Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
Functional mobility was assessed by the Timed Up and Go Test (TUG).
During the test, the individuals were asked to get up from the chair, walk 3 meters, turn around, walk back to the chair, and sit down.
The score was the total time in seconds to complete the task.
In the study, the test was repeated three times, and the average time was recorded.
|
From enrollment to the end of treatment at 6 weeks
|
|
The 6-Minute Walk Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
Walking performance and functional exercise capacity were assessed using the Six-Minute Walk Test (6-MWT).
Participants were instructed to walk at the highest speed they felt safe in a 30-meter straight pathway for six minutes.
The score was the total walking distance in meters at the end of the test.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Limits of Stability Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
The Limits of Stability Test was assessed with The Biodex-Biosway Portable Balance System (Biodex Medical System Inc., Shirley, NY, USA).
During the test, the individuals were asked to move their bodies toward target points displayed on the screen without lifting their feet and then return to the center point.
During this movement, they were instructed to move as quickly and accurately as possible.
The test results in a total percentage score.
A lower score indicates decreased stability limits.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Postural Stability Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
The Postural Stability Test was assessed with The Biodex-Biosway Portable Balance System (Biodex Medical System Inc., Shirley, NY, USA).
The test evaluates static balance by assessing the individual's ability to maintain their center of gravity over the support surface while standing.
During the test, the individuals were asked to stand as still as possible.
The test duration was 30 seconds and a total stability index score was calculated.
The stability index scores range from 0 to 4, with lower scores indicating good postural stability.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Modified Sensory Organization Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
The Modified Sensory Organization Test (MSOT) was assessed with the Biodex-Biosway Portable Balance System (Biodex Medical System Inc., Shirley, NY, USA).
In the test, by selectively disrupting visual and somatosensory inputs, it is determined which sensory inputs the individual relies on the most to maintain postural stability.
The MSOT was performed under four conditions in the study: eyes open on a firm surface, eyes closed on a firm surface, eyes open on a soft surface, and eyes closed on a soft surface.
The individuals were instructed to maintain their balance in all conditions.
The test duration was 30 seconds for each condition.
The sway index scores were calculated at the end of the test.
The sway index scores range from 0 to 4, with lower sway index scores indicating decreased postural sway.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Side-bridge Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
The side-bridge test was used to assess core muscle endurance.
The individuals were positioned in a straight line, lying on their left or right side with their legs fully extended.
The individuals were asked to lift their body on forearms and toes, and maintain this position for as long as possible.
When the individual was unable to maintain the position, the test was terminated.
The score was the total time in seconds to complete the task.
In the study, the test was performed twice, and the longer duration was recorded.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Biering-Sorensen Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
The Biering-Sorensen test was used to assess core muscle endurance.
In this test, the individuals were asked to lie prone on a workout bench, aligning their anterior superior iliac spine with the edge of the bench, allowing the upper body to extend over the edge.
An assisting partner secured the individuals' knees, hips, and pelvis.
The individuals were instructed to fold their arms across their chest and to hold this position for as long as possible.
When the individual was unable to maintain the position, the test was terminated.
The score was the total time in seconds to complete the task.
In the study, the test was performed twice, and the longer duration was recorded.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Trunk Flexor Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
The trunk flexor test was used to assess core muscle endurance.
The individuals were positioned in a sit-up position with their back resting against a wedge angled at 60° from the floor.
After the wedge was removed, they were asked to maintain this position for as long as possible.
When the individual was unable to maintain the position, the test was terminated.
The score was the total time in seconds to complete the task.
In the study, the test was repeated twice, and the longer duration was recorded.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Prone Bridge Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
The prone bridge test was used to assess core muscle endurance.
In this test, the individuals were asked to raise their bodies in a prone position, supporting themselves on their forearms and toes with their elbows flexed, maintaining this position for as long as possible.
When the individual was unable to maintain the position, the test was terminated.
The score was the total time in seconds to complete the task.
In the study, the test was repeated twice, and the longer duration was recorded.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Sit-ups Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
The sit-ups test was used to assess core muscle strength.
The test began when the individuals were instructed to ''go'', and they were asked to lift their upper body off the floor, raising the lower corner of the scapula.
The score was recorded as the number of repetitions completed in 30 seconds.
In the study, the test was performed twice, and the highest number of repetitions was recorded.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Modified Push-ups Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
The modified push-ups test was used to assess core muscle strength.
The individuals were positioned on their hands and knees with hands shoulder-width apart and elbows fully extended.
They dropped their hips and moved their hands forward until they created a straight line and a straight back from the knees to the hips to the shoulders.
During the test, the individuals were asked to maintain this straight position while lowering their upper body until their elbows were bent to 90°, then pushing back up to the starting position.
The score was recorded as the number of repetitions completed in 30 seconds.
In the study, the test was performed twice, and the highest number of repetitions was recorded.
|
From enrollment to the end of treatment at 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Nine-Hole Peg Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
Upper extremity performance was assessed using the Nine-Hole Peg Test (9-HPT).
The 9-HPT consists of a pegboard with 9 holes and 9 wooden pegs.
Individuals were asked to place and remove all 9 pegs one at a time as fast as possible.
The score was the total time in seconds to complete the task.
In the study, the test was repeated twice for each extremity, and the average time was recorded for each side.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Fatigue Severity Scale
Time Frame: From enrollment to the end of treatment at 6 weeks
|
The Fatigue Severity Scale (FSS) assesses the severity of fatigue in the last month.
It consists of 9 items, and the items are scored from 1 (strongly disagree) to 7 (strongly agree).
The mean of the nine item scores is used as the FSS score.
The scores that can be obtained from the test are between 1 and 7, and high scores indicate the presence of fatigue.
|
From enrollment to the end of treatment at 6 weeks
|
|
The Fatigue Impact Scale
Time Frame: From enrollment to the end of treatment at 6 weeks
|
The Fatigue Impact Scale (FIS) assesses the impact of fatigue on physical, cognitive, and psychosocial functions in the last four weeks.
It consists of 40 questions, with responses ranging from 0 (no problem) to 4 (extreme problem).
The scores that can be obtained from the test are between 0 and 160, and high scores indicate a greater fatigue effect.
|
From enrollment to the end of treatment at 6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Arzu GUCLU GUNDUZ, Professor Doctor, Gazi University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-1602
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Pilates
-
Istanbul Medipol University HospitalCompleted
-
Universidade Cidade de Sao PauloCompleted
-
University of Colorado, Colorado SpringsUniversity of Illinois at Urbana-ChampaignCompleted
-
Istanbul Medipol University HospitalCompleted
-
Universidade Federal de Santa MariaCompleted
-
Pontificia Universidade Católica do Rio Grande...Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo... and other collaboratorsCompletedAging | Mobility Limitation | Postural BalanceBrazil
-
Uskudar UniversityCompletedOccupational DiseasesTurkey (Türkiye)
-
Michele de Aguiar ZacariaRecruiting
-
Istanbul Medipol University HospitalCompleted
-
Uskudar UniversityCompletedLow Back Pain | Kinesiophobia | Disc HerniationTurkey (Türkiye)